1. Home
  2. BBNX vs ASA Comparison

BBNX vs ASA Comparison

Compare BBNX & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • ASA
  • Stock Information
  • Founded
  • BBNX 2015
  • ASA 1958
  • Country
  • BBNX United States
  • ASA United States
  • Employees
  • BBNX N/A
  • ASA N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • ASA Precious Metals
  • Sector
  • BBNX Health Care
  • ASA Industrials
  • Exchange
  • BBNX Nasdaq
  • ASA Nasdaq
  • Market Cap
  • BBNX 967.6M
  • ASA 945.7M
  • IPO Year
  • BBNX 2025
  • ASA N/A
  • Fundamental
  • Price
  • BBNX $21.86
  • ASA $44.36
  • Analyst Decision
  • BBNX Strong Buy
  • ASA
  • Analyst Count
  • BBNX 11
  • ASA 0
  • Target Price
  • BBNX $26.09
  • ASA N/A
  • AVG Volume (30 Days)
  • BBNX 540.2K
  • ASA 168.8K
  • Earning Date
  • BBNX 10-28-2025
  • ASA 11-07-2025
  • Dividend Yield
  • BBNX N/A
  • ASA 0.13%
  • EPS Growth
  • BBNX N/A
  • ASA 335.96
  • EPS
  • BBNX N/A
  • ASA 19.90
  • Revenue
  • BBNX $78,022,000.00
  • ASA $3,982,215.00
  • Revenue This Year
  • BBNX $43.04
  • ASA N/A
  • Revenue Next Year
  • BBNX $35.60
  • ASA N/A
  • P/E Ratio
  • BBNX N/A
  • ASA $2.28
  • Revenue Growth
  • BBNX 550.45
  • ASA 99.75
  • 52 Week Low
  • BBNX $8.89
  • ASA $19.37
  • 52 Week High
  • BBNX $26.66
  • ASA $53.76
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 54.20
  • ASA 46.02
  • Support Level
  • BBNX $19.52
  • ASA $43.55
  • Resistance Level
  • BBNX $22.54
  • ASA $46.56
  • Average True Range (ATR)
  • BBNX 1.36
  • ASA 2.00
  • MACD
  • BBNX -0.07
  • ASA -0.90
  • Stochastic Oscillator
  • BBNX 60.15
  • ASA 7.93

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: